Article Text

PDF
Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female
  1. Hassan Al-Dhibi1,
  2. Imtiaz A Chaudhry2,
  3. Annoud Al-Saati3,
  4. Farrukh A Shamsi4
  1. 1
    Retina Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  2. 2
    Oculoplastic and Orbit Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  3. 3
    Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia
  4. 4
    Research Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  1. Dr Imtiaz A Chaudhry, Oculoplastic and Orbit Division, King Khaled Eye Specialist Hospital, PO Box 7191, Riyadh 11462, Saudi Arabia; orbitdr{at}hotmail.com

Statistics from Altmetric.com

After diabetic retinopathy, retinal venous occlusion (RVO) is the most common cause of retinopathy leading to severe visual loss in all age groups. Generally, RVO is associated with systemic diseases with significant morbidity and mortality. The risk of RVO is increased in patients older than 65 years of age with systemic hypertension, cardiovascular disease, diabetes and obesity.1 Patients younger than 50 years of age may have other underlying conditions requiring appropriate investigation and treatment.2 3 We describe the development of central retinal venous occlusion (CRVO) and the efficacy of intravitreal triamcinolone acetonide injection (IVTA) for associated cystoid macular oedema (CME) in a young healthy woman after she was started on systemic multiple anti-androgen therapy for treatment of hirsutism.

Case report

A 24-year-old woman with a 4-month history of painless loss of vision and a diagnosis of CRVO in her left eye (OS) was referred for further evaluation and management. Her ocular history revealed squint surgery and amblyopia in her right eye (OD) since childhood. …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.